RO7623066

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7623066, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors [Phase 1]